This project would appeal to those with interests in pharmaceutical applications of medicinal and protein chemistry.
Pseudomonas aeruginosa is the most common respiratory pathogen in patients with cystic fibrosis and causes systemic infections in patients who are immunosuppressed as a result of severe burns, cancer and AIDS. This project will build upon our initial results (from a project aimed at developing new agents for the detection of this bacterium [PW Groundwater et al., Org. & Biomol. Chem., 2008, 8, 682; doi: 10.1039/b716978g]) and will aim to selectively release specific antibiotics within Pseudomonas aeruginosa, thereby improving their uptake and efficacy. This project would appeal to those with interests in pharmaceutical applications of medicinal and protein chemistry.
The opportunity ID for this research opportunity is 938